These results lend support to the clinical and cross-cultural validity of the QLQ-BR23 as a supplementary questionnaire for assessing specific quality-of-life issues relevant to patients with breast cancer.
No takes yet. Share an insight, caveat, or question.
Sprangers et al. (1996) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: